Currently Viewing:
Newsroom
Currently Reading
What We're Reading: High Court Lets Abortion Cases Stand; NIH and Fetal Tissue; Dsuvia Examined
December 11, 2018 – AJMC Staff
Rate of Uninsured Increased in 2017 for the First Time Since 2014
December 11, 2018 – Allison Inserro
More Than 300 Groups Seek Halt to CMS' Plans for Global Drug Pricing Index
December 10, 2018 – Allison Inserro
Study Confirms Safe Use of Opioids for Pain Control in Sickle Cell Disease
December 10, 2018 – Jackie Syrop
Premature Birth May Induce Variability in the Mother's Systolic Blood Pressure
December 10, 2018 – AJMC Staff
Coalition Agrees on Need to Protect Patients From Surprise Medical Bills
December 10, 2018 – Allison Inserro
What We're Reading: Democrats Split Over Single Payer; Generic Drug Probe; Virginia Work Requirements
December 10, 2018 – AJMC Staff
What Might Come After the Oncology Care Model
December 10, 2018 – Laura Joszt
Some Lifestyle Factors Positively Impact Depression in People With Multiple Sclerosis
December 09, 2018 – Laura Joszt

Chronic Migraine Associated With Comorbidities, Sleep Disorders

Jaime Rosenberg
Chronic migraine is associated with pain, psychiatric, and endocrine/neurological comorbidities, as well as sleep disorders.
Chronic migraine is associated with pain, psychiatric, and endocrine/neurological comorbidities, as well as sleep disorders, according to 2 study abstracts presented at the Annual Academy of Neurology Meeting, held April 21-27 in Los Angeles, California.

Both studies analyzed data from the prospective web-based baseline survey of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Data were extracted to identify people with episodic migraine and chronic migraine. Survey participants answered the Comorbidities/Endophenotypes module assessing 64 symptoms and conditions. Participants were asked if they ever had a specific symptom and, if they did, if the symptom or condition had been confirmed or diagnosed by a doctor.

Of the 12,810 participants, 11,699 had episodic migraine, and 1,111 had chronic migraine. The 2 cohorts were similar in age, with a mean age of 41.3 in the episodic migraine cohort and a mean age of 41.9 in the chronic migraine cohort. Those in the chronic migraine cohort were more likely to be women (81.5% vs 74.2%), white (88.7% vs 84%), and have a higher body mass index (28.7 kg/m2 vs 27.7 kg/m2).

The first study focused on pain, psychiatric, and endocrine/neurological comorbidities reported. The researchers observed that there were 5 conditions with relative frequencies of 10% or more that were more prevalent in those with chronic migraine: chronic back pain (37.5% vs 22.5%), chronic pain (22.2% vs 7.4%), neck pain (55.3% vs 38.1%), anxiety (42.2% vs 25.7%), and depression (45.6% vs 28.1%).

“Significantly more respondents with chronic migraine versus episodic migraine reported having specific symptoms or conditions,” concluded the authors of the study. “Mechanisms explaining this association might have direct causality (chronic migraine causes the comorbidity), reverse causality (the condition increases chronic migraine risk), and shared genetic or environmental risk factors.”

Noting previous reports of sleep pattern disorders and sleep apnea being associated with increased headache severity in chronic migraine, the second study set its focus on the relationship between migraine and sleep disorders. Of the 12,810 participants, 37% were at “high risk” for sleep apnea, with 35.6% of those with episodic migraine being at high risk and 51.8% of those with chronic migraine being at high risk.

The chronic migraine cohort was also more likely to experience snoring (33.9% vs 32.1%), shortness of breath (29.8% vs 20.6%), daytime somnolence (23.4% vs 21.2%), and sleep inadequacy (24.2% vs 22.1%).

Related Articles

Amgen, Novartis Announce Positive Results of Erenumab Trial for Episodic Migraine
Noninvasive Single-Pulse Stimulation Device Can Help Prevent Migraines, Study Finds
Women With Migraine More Likely to Develop Hypertension
86 Million Workdays Lost Annually to Migraine in the UK
Institute for Patient Access Issues Response to ICER Review of CGRP Inhibitors for Migraine
 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!